Continuing Education
Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics
Revolucionando el tratamiento del cáncer de Próstata: la terapia dirigida al antígeno prostático específico en el enfoque moderno terapéutico
A. Ricaurte-Fajardoa,b,1, V. Marulanda-Corzoa,1,
, S. Ruderc, D.R. Cardoza-Ochoad, C.E. Granadose, D. Yadava, D. López-Delgadof, M. Fatimac, S. Dutruela, E. O’Dwyera, J.R. Osbornea, S.T. Tagawac, S. Huicochea Castellanosa
Corresponding author
a Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, United States
b Department of Neurosciences, Division of Neurology, Pontificia Universidad Javeriana, Bogotá, Colombia
c Department of Internal Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, United States
d Department of Radiology, Division of Nuclear Medicine, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
e Functional Unit of Diagnostic Imaging and Nuclear Medicine, Luis Sarmiento Angulo Cancer Treatment and Research Center, Bogotá, Colombia
f Department of Internal Medicine, Universidad Cooperativa de Colombia, Pasto, Colombia
